News Agency
The Times

A Treatment Option for Metastatic Colorectal Cancer Patients with BRAFV600E Mutation in Singapore

  • Written by Media Outreach

Targeted therapy regimen, BRAFTOVI® (encorafenib) in combination with cetuximab, included on MOH Cancer Drug List, for the treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer who have received prior systemic therapy.

SUMMARY OF KEY POINTS
  • BRAFTOVI in combination with cetuximab has been included on MOH CDL, for...

Read more: A Treatment Option for Metastatic Colorectal Cancer Patients with BRAFV600E Mutation in Singapore

Selecting Steel Plate for Industrial and Fabrication Projects

Start with the job requirements A successful fabrication project starts with material that suits the work it must perform. Choosing steel plate involves more than selecting a thickness from a stock list. Designers and procurement teams need to consider the load... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion